WHAT´S NEW in Psoraisis?

In this section you will be able to identify the new content uploaded regularly . 

Duration 3:28

 Abbvie

-

 

"This shows Current understanding of the role of IL-23 in immun-mediated skin diseases"

 

Duration 14:14

Prof. Melinda Gooderham

Speaker, investigator or advisory board member for AbbVie, Actelion, Amgen, Akros, Arcutis, Arena, Bausch, Boehringer Ingelheim, BMS, Celgene, Coherus, Dermira, Eli Lilly, Galderma, Glenmark, GSK, Janssen, Kyowa Kirin, LEO Pharma, MedImmune, Merck, Novartis, Pfizer, Regeneron, Roche Laboratories, Sanofi Genzyme, Sun Pharmaceuticals, Takeda, UCB and Valeant 

 

" Clinical practice and experience with IL-23 video"

Duration 4:34

Prof. Richard Warren

Professor of Dermatology and Therapeutics and Honorary Consultant Dermatologist, Salford Royal NHS Foundation Trust,  and University of Manchester, UK

 

" Clinical Skin Clearance: Chances to change the life course for patients with psoriasis "

Duration 2:18

 Abbvie

-

 

" From Immunology to Clinic: A Journey through the understanding of Psoriasis Pathophysiology"

Duration 21:24

 Prof. Richard Warren

Professor of Dermatology and Therapeutics and Honorary Consultant Dermatologist, Salford Royal NHS Foundation Trust,  and University of Manchester, UK 

 

"Aiming for early clearance in psoriasis to alter life course impairment "

 

For Oman HCPs.

Department of Pharmacovigilance & Drug information.

Directorate General of pharmaceutical affairs and Drug control.

Ministry of Health, Sultanate of Oman

Phone Nos:: 22357687 / 22357686

Fax: 22358489

Email: [email protected]

Website:www.moh.gov.om

 

 

This website is intended for Gulf Healthcare Professionals

AbbVie Biopharmaceuticals GmbH.

 

Suite 2901, U Bora Tower,Business Bay, Dubai, UAE

PO Box:: 118052

OFFICE : +971 4 5506100

FAX: +971 4 5506101

Patient Safety is our Priority, we will remain always by your side. For Reporting Adverse events Please Contact.

[email protected] or Hotline: 00971564135746

JAKa-BH-00004-MC